EMV Capital

EMV Capital is a London-based venture capital firm specializing in early-stage, high-growth deep tech companies. Their primary focus spans the life sciences, sustainability, and industrial sectors. With a hands-on approach, EMV Capital supports portfolio companies by providing strategic guidance, capital structuring, and operational involvement, aiming to drive transformational growth. The firm operates globally, leveraging its extensive network of corporate partnerships, private investors, and family offices to support innovation. EMV Capital's investment strategy is unique in its focus on capital-light models, blending equity with grants, debt, and corporate partnerships. Their portfolio includes companies like Vortex Biotech, Sofant, and Q-Bot, leaders in areas ranging from circulating tumor cell technology to robotics for construction. The firm’s commitment to active portfolio management is evident through their value-creation services, which include support for business planning, recruitment, and financial modeling. Founded and managed by Dr. Ilian Iliev, EMV Capital is a wholly owned subsidiary of NetScientific, a publicly listed company on AIM. Their recent collaboration with Martlet Capital strengthens their footprint in the deep-tech space, particularly within the Cambridge high-tech cluster, further solidifying their leadership in the UK and Europe.